eScholarship
metadata only
An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats
BACKGROUND: Pharmacological inhibition of soluble epoxide hydrolase (sEH) enhances the synaptic function in the CNS and has a protective role in cognitive decline. We hypothesized that the sEH inhibitor TPPU might prevent the diabetes-induced decline in learning and memory which is associated with a
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Diabetes-Associated Cognitive Dysfunction: Pathophysiology, Molecular Mechanisms, and Emerging Therapeutic Strategies.#1346456
- Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes#905149
- Effect of MetS* on Cognitive Performance and Physical Activity (Metabolic Syndrome)#891460
- HIPPOCAMPAL CIRCUIT ALTERATIONS AND MICROGLIAL CONTRIBUTIONS TO LEARNING AND MEMORY DYSFUNCTIONS FOLLOWING MILD TRAUMATIC BRAIN INJURY#929479
- Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment#1170592
Record · ID 1373213
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive